BASE EXCISION REPAIR AND MECHANISMS OF ALKYLATING AGENT INDUCED P53 DAMAGE

碱基切除修复和烷基化剂诱导 P53 损伤的机制

基本信息

项目摘要

The base excision repair pathway is responsible for repair of DNA lesions generated by ionizing radiation, oxidative damage, and alkylation damage. It has not been investigated as thoroughly as has the nucleotide excision repair pathway. DNA alkylating agents used in chemotherapy generate cytotoxic DNA lesions which are responsible for the tumor killing effect of these agents. The 3-methyladenine-DNA glycosylases from bacterial, rodent, and mammalian sources catalyze the first repair step, base excision, of many alkylated lesions. To identify the range of alkylated substrates repaired by these three enzymes, DNA will be modifies by a variety of alkylating agents including chemotherapeutic agents such as nitrogen mustards, chloroethyl-nitrosoureas, and cyclophosphamide. Rates of cleavage, in vitro repair, at each base position will be determined for bacterial, rat, and human 3meAdenine glycosylases. In vivo repair rates for dimethyl sulfate and bischloroethylnitrosourea will be mapped at the nucleotide level of resolution along the PGK1 promoter and p53 exons in normal human male fibroblasts using the ligation-mediated Polymerase Chain Reaction (LMPCR). These data will provide information on sequence context and chromatin dependence for base excision repair rates. A PCR-based primer extension assay to replace the Bohr-Hanawalt assay for repair rates, will be developed to produce a population screening assay for activity of all major repair pathways. This assay will be used to test the hypothesis "Many brain tumors resistant to a combination of bischloroethylnitrosourea and 06benzylguanine are resistant because they overexpress 3meadenine DNA glycosylase activity."
碱基切除修复途径负责DNA损伤的修复

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GERALD P HOLMQUIST其他文献

GERALD P HOLMQUIST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GERALD P HOLMQUIST', 18)}}的其他基金

BASE EXCISION REPAIR AND MECHANISMS OF ALKYLATING AGENT INDUCED P53 DAMAGE
碱基切除修复和烷基化剂诱导 P53 损伤的机制
  • 批准号:
    6103191
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
TUMORIGENICITY OF DIFFERENT P53 MISSENSE MUTATIONS
不同 P53 错义突变的致瘤性
  • 批准号:
    2465352
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
TUMORIGENICITY OF DIFFERENT P53 MISSENSE MUTATIONS
不同 P53 错义突变的致瘤性
  • 批准号:
    2871994
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF ULTRAVIOLET LIGHT INDUCED P53 MUTATIONS
紫外线诱导 P53 突变的机制
  • 批准号:
    6103189
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
TUMORIGENICITY OF DIFFERENT P53 MISSENSE MUTATIONS
不同 P53 错义突变的致瘤性
  • 批准号:
    6150297
  • 财政年份:
    1998
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF ULTRAVIOLET LIGHT INDUCED P53 MUTATIONS
紫外线诱导 P53 突变的机制
  • 批准号:
    6237667
  • 财政年份:
    1997
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF P53 MUTAGENESIS
P53 诱变机制
  • 批准号:
    2769833
  • 财政年份:
    1996
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF P53 MUTAGENESIS
P53 诱变机制
  • 批准号:
    2113515
  • 财政年份:
    1996
  • 资助金额:
    $ 24.85万
  • 项目类别:
MECHANISMS OF P53 MUTAGENESIS
P53 诱变机制
  • 批准号:
    2517693
  • 财政年份:
    1996
  • 资助金额:
    $ 24.85万
  • 项目类别:
ADDUCT AND REPAIR MAPPING IN ONCOGENES
癌基因中的加合物和修复图谱
  • 批准号:
    3199311
  • 财政年份:
    1991
  • 资助金额:
    $ 24.85万
  • 项目类别:

相似海外基金

DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 24.85万
  • 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
  • 批准号:
    2338236
  • 财政年份:
    2024
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Continuing Grant
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
  • 批准号:
    2246561
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Standard Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
  • 批准号:
    23K07078
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DNA Repair State Machines
DNA 修复状态机
  • 批准号:
    EP/X027406/1
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Research Grant
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
  • 批准号:
    23H05475
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
  • 批准号:
    10734425
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
  • 批准号:
    10666307
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
  • 批准号:
    10651048
  • 财政年份:
    2023
  • 资助金额:
    $ 24.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了